Patent · US Active

Pyruvate kinase activators for use in therapy

US11793806B2 · kind B2 · utility

2Cited by
69References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 2, 2021
Grant dateOct 24, 2023
Priority date—
Expiry dateMar 12, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods for using compounds that activate pyruvate kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.